On-Q-ity Information

On-Q-ity is a life science company dedicated to the improvement of cancer patient outcomes through enhancing drug development and enabling clinicians to confidently tailor and evolve treatment decisions. More than just numbers, Circulating Tumor Cells (CTCs) have the potential for identifying clinically significant events unique to each patient at each point in time. On-Q-ity's robust CTC isolation and analysis platform uniquely utilizes this dynamic biomarker to provide the most accurate, complete and actionable information possible to address yet un-met clinical needs. Through our multi-tiered approach, CTCs reach their potential for illuminating the pathway by which cancer evolves. On-Q-ity is currently in the early stages of clinical development, and invites collaborative opportunities utilizing its proprietary RUO system, including: - Patient Sample Analysis - Integration of Custom Antibodies - Integration with your own Analysis Platform - eCTC Analysis Results - Custom Assay Development - Combination of eCTC Analysis and Molecular Results